Sonnet Biotherapeutics 獲股東批准與 Hyperliquid Strategies Inc 進行業務合併
ChainCatcher 消息，据市場消息，納斯達克上市生物科技公司 Sonnet Biotherapeutics 已獲得股東批准，擬與 Hyperliquid Strategies Inc 進行業務合併。
此前消息，Hyperliquid Strategies 提交 S-1 文件，擬募資最高 10 億美元或用於購入 HYPE 代幣。
風險提示 風險提示
BTC $84,581.91 -0.72%
ETH $2,681.06 -1.20%
BNB $768.73 -0.59%
XRP $1.49 -1.05%
SOL $119.08 -0.81%
TRX $0.3343 -0.01%
DOGE $0.0931 -1.14%
ADA $0.2475 -0.25%
BCH $312.31 +1.44%
LINK $13.94 -2.99%
HYPE $88.29 -0.48%
AAVE $180.85 +3.32%
SUI $1.15 -1.25%
XLM $0.2159 -1.55%
ZEC $1,324.16 -0.38%
AAPL $333.42 +0.67%
AMZN $251.78 +0.98%
GOOGL $343.82 +1.17%
MSFT $518.03 +0.38%
META $727.30 -0.20%
NVDA $234.34 +1.13%
TSLA $370.88 +4.18%
SNDK $1,719.65 -3.76%
INTC $118.62 -1.76%
SPCX $158.91 +6.55%
MU $1,067.98 -2.10%
AMD $634.53 +2.35% BTC $84,581.91 -0.72% ETH $2,681.06 -1.20% BNB $768.73 -0.59% XRP $1.49 -1.05% SOL $119.08 -0.81% TRX $0.3343 -0.01% DOGE $0.0931 -1.14% ADA $0.2475 -0.25% BCH $312.31 +1.44% LINK $13.94 -2.99% HYPE $88.29 -0.48% AAVE $180.85 +3.32% SUI $1.15 -1.25% XLM $0.2159 -1.55% ZEC $1,324.16 -0.38% AAPL $333.42 +0.67% AMZN $251.78 +0.98% GOOGL $343.82 +1.17% MSFT $518.03 +0.38% META $727.30 -0.20% NVDA $234.34 +1.13% TSLA $370.88 +4.18% SNDK $1,719.65 -3.76% INTC $118.62 -1.76% SPCX $158.91 +6.55% MU $1,067.98 -2.10% AMD $634.53 +2.35%
風險提示 風險提示
ChainCatcher 與創新者共建Web3世界
